ASCO-QC 2022 - 2022 ASCO Quality Care Symposium
Sep 30 - Oct 01, 2022 | ChicagoILUS
LARVOL is not affiliated with 2022 ASCO Quality Care Symposium and all trademarks, logos, and brand names are property of their respective owners
Showing 27 abstracts linked to Trials
A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39).
Intervention non-adherence in a pragmatic randomized trial of a standardized order entry for colony stimulating factor prescribing.
Enrollment patterns and site-level predictors of Black participant recruitment to a multisite randomized clinical trial (RCT) of endocrine therapy adherence support.
An augmented intelligence mobile phone chatbot for medication adherence and toxicity management among patients with gastrointestinal cancers on capecitabine.
12-month secondary outcomes of a prostate cancer survivor symptom self-management intervention.
Patient-reported outcomes in a linguistically diverse cancer population: Addressing barriers to access.
Postoperative symptom monitoring with ePROs in an academic public hospital.
Impact of adverse events on independence in daily functioning of older adults with advanced cancer treated with systemic therapy.
Impact of acute toxicities associated with chimeric antigen receptor (CAR) T-cell therapy on health-related quality of life (HRQOL) in relapsed or refractory (R/R) large B-cell lymphoma (LBCL).
Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia.
Modifiable risk factors for falls among older adults with advanced cancer.
Smartphone pain app for assessment of radiation-induced oral mucositis pain.
Evaluating the use of web versus mobile devices for ePRO reporting and severe symptom responses at 6 cancer centers.
Severe symptom reporting in medical oncology patients at community cancer centers assessed through eSyM.
Severe symptom reporting in surgical patients assessed through an EHR-integrated ePRO questionnaire at 6 cancer centers.